Tissue-specific tumour suppression by APC

Advances in Experimental Medicine and Biology

Volumn 656, Issue , 2009, Pages 107-118

  Sansom, Owen ^a  

^a BEATSON INSTITUTE FOR CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN D1; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; WNT PROTEIN;

ADENOMATOUS POLYPOSIS COLI GENE; ALLELE; ARTICLE; BREAST CANCER; CANCER INHIBITION; CELL PROLIFERATION; COLON CANCER; COLON CARCINOGENESIS; DOWN REGULATION; ENZYME ACTIVATION; GENE DELETION; GENE LOCATION; INTESTINE EPITHELIUM; KIDNEY CANCER; LIVER CELL CARCINOMA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TISSUE SPECIFICITY; TUMOR SUPPRESSOR GENE; UPREGULATION; ANIMAL; COLORECTAL TUMOR; GENETICS; METABOLISM; MOUSE; PHYSIOLOGY; REVIEW;

MUS;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; COLORECTAL NEOPLASMS; GENE DELETION; GENES, APC; GENES, TUMOR SUPPRESSOR; MICE; SIGNAL TRANSDUCTION; WNT PROTEINS;

EID: 75349088233     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4419-1145-2_9     Document Type: Article

References (55)

1. Su LK, Kinzler KW;VogelsteinB et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992: 256(5057):668-670.
2. Luongo C, Moser AR, Gledhill S et al. Loss of Apc+ in intestinal adenomas from Min mice. Cancer Res 1994: 54(22) :5947-5952. (Pubitemid 24375232)
3. Oshima M, DinchukJE, Kargman SL et al. Suppression of intestinal polyposis in APC delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 1996; 87(5) :803-809. (Pubitemid 26404280)
4. Yang K, Edelmann W; Fan K et al. A mouse model of human familial adenomatous polyposis. J Exp Zool 1997: 277(3) :245-254. (Pubitemid 27134192)
5. S. Sauer B, Henderson N. Site-specific DNA recombinat ion in mammalian cells by the Cre recombinase of bacteriophage PI. Proc Natl Acad Sci USA 1988; 85(14) :SI66-5170.
6. Shibata H, Toyama K, Shioya H et al. Rapid colorectal adenoma formation initiated by conditional targeting of the APC gene. Science 1997; 278(5335):120-123.
7. Soriano P. Generalized lacZ expression with the ROSA26 Cre reporter straln. Nat Genet 1999; 21(1) :70-71. (Pubitemid 29036285)
8. Marshman E, Booth C, Potten CS. The intestinal epithelial stem cell. Bioessays 2002: 24(1) :91-98. (Pubitemid 34108424)
9. Bach SP, Renehan AG, Potten CS. Stem cells: the intestinal stem cell as a paradigm. Carcinogenesis 2000; 21(3) :469-476. (Pubitemid 30137932)
10. Ireland H, Kemp R, Houghton C et al. Inducible Cre-mediated control of gene expression in the murine gastrointestinal tract : effect of loss of beta-catenin. Gastroenterology 2004; 126(5) :1236-1246. (Pubitemid 38552788)
11. Andreu P, Colnot S, Godard C et al. Crypt-restricted proliferation and commitment to the paneth cell lineage following APC loss in the mouse intestine. Development 2005: 132(6):1443-1451. (Pubitemid 40528801)
12. Campbell SJ, Carlotti F, Hall PA et al. Regulation of the CYP1a1 promoter in transgenic mice: an exquisitely sensitive on-off system for cell specific gene regulation. J Cell Sci 1996: 109(Pt 11):2619-2625. (Pubitemid 26388347)
13. Sansom OJ, Reed KR, Hayes AJ et al. Loss of APC in vivo immediately perturbs wnt signaling, differentiation and migration. Genes Dev 2004: 18(12):1385-1390. (Pubitemid 38780625)
14. Sansom OJ, Reed KR, van de Wetering M et al. Cyclin D1 is not an immediate target of beta-catenin following APC loss in the intestine. J Biol Chem 2005: 280(31 ):28463-28467. (Pubitemid 41105745)
15. Dikovskaya D, Schiffmann D, Newton IP et al. Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol 2007 ; 176(2) :183-195. (Pubitemid 46143259)
16. Bienz M, Clevers H. Linking colorecral cancer to Wnt signaling. Cell 2000; 103(2) :311-320.
17. Pinto D, Gregorieff A, Begthel H et al. Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 2003; 17(14) :1709-1713. (Pubitemid 36870334)
18. Gregorieff A, Pinto D, Begthel H et al. Expression pattern of wnt signaling components in the adult intestine. Gastroenterology 2005; 129(2) :626-638. (Pubitemid 41096648)
19. Reed KR, Sansom OJ, Hayes AJ et al. PPARdelta status and APC-mediated tumourigenesis in the mouse intestine. Oncogene 2004; 23(55) :8992-8996. (Pubitemid 39657790)
20. He TC, Chan TA, Vogelstein B et al. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 1999; 99(3):335-345. (Pubitemid 29519912)
21. Harman FS, Nicol CJ. Marin HE et al. Peroxisome proliferator-acnvated receptor-delta attenuates colon carcinogenesis. Nat Med 2004; 10(5):481-483. (Pubitemid 38667905)
22. Tersu O, McCormick F.Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999: 398(6726):422-426. (Pubitemid 29180374)
23. Labbe E, Lock L. Letamendia A et al. Transcriptional cooperation betwe en the transforming growth factor-beta and Wnt pathways in mammary and intestinal tumorigenesis. Cancer Res 2007; 67( 1):75-84. (Pubitemid 46142761)
24. Wilson A, Murphy MJ, Oskarsson T et al. C-myc controls the balance between hematopoietic stem cell self-renewal and differentiation. Genes Dev 2004; 18(22):2747-2763. (Pubitemid 39507768)
25. Pelengaris S, Khan M, Evan GI. Suppression of myc-induced apoptosis in beta cells exposes multiple oncogenic properties of myc and triggers carcinogenic progression. Cell 2002: 109(3) :321-334. (Pubitemid 34606875)
26. DavisAC, Wims M, Spotrs GD et al. A null c-myc mutation causeslethality before 10.5 days ofgestation in homozygotes and reduced fertility in heterozygous female mice. Genes Dev 1993; 7(4 ):671-682. (Pubitemid 23125266)
27. Bettess MD. Dubois N, Murphy MJ et al. C-myc is required for the formation of intestinal crypts bur dispensable for homeostasis of the adult intestinal epithelium. Mol Cell Biol 2005; 25(17) :7868-7878. (Pubitemid 41170145)
28. Muncan V, Sansom OJ. Tertoolen L et al. Rapid loss of intestinal crypts upon conditional deletion of the wnt/TCF-1 target gene c-myc. Mol Cell Biol 2006: 26(22) :8418-8426. (Pubitemid 44748575)
29. Sansom OJ. Mcniel VS, Muncan V et al. Myc deletion rescues APC deficiency in the small intestine. Nature 2007: 446(7136):676-679. (Pubitemid 46606884)
30. Batlle E, Henderson JT, Beghtel H et al. Beta-catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 2002; 111(2) :251-263. (Pubitemid 35292445)
31. Malliri A, Rygiel TP, van der Kammen RA et al. The rac activator tiarn1 is a wnt-responsive gene that modifies intestinal tumor development. J Biol Chem 2006; 281(1) :543-548. (Pubitemid 43671217)
32. Mogensen MM, Tucker JB, Mackie JB et al. 'The adenomatous polyposis coli protein unambiguously localizes to microtubule plus ends and is involved in establishing parallel arrays of microtubule bundles in highly polarized epithelial cells. J Cell Biol 2002; 157(6):1041-1048. (Pubitemid 34839778)
33. Narhke I. Cytoskeleton out of the cupboard: colon cancer and cyroskeletal changes induced by loss of APC. Nat Rev Cancer 2006; 6(12) :967-974.
34. Kaplan KB, Burds AA, SwedlowJR et al. A role for the adenomatous polyposis coli protein in chromo some segregation. Nat Cell Biol 2001; 3(4) :429-432. (Pubitemid 32288453)
35. Smits R, Kielman MF, Breukel C et al. Apcl638T: a mouse model delineating critical domalns of the adenomatous polyposis coli protein involved in tumorigenesis and development. Genes Dev 1999; 13(10):1309-1321. (Pubitemid 29250198)
36. Lee HC, Kim M, Wands JR. Wnt/frizzled signaling in hepatocellular carcinoma. Front Biosci 2006; 11:1901-1915. (Pubitemid 43253403)
37. Bcnhamouche S, Decaens T, Godard C et al. APC tumor suppressor gene is the "zonation-keeper" of mouse liver. Dev Cell 2006; 10(6):759-770. (Pubitemid 43796151)
38. Tan X, Behari J, Cieply B et al. Conditional deletion of beta-catcnin reveals its role in liver growth and regeneration. Gastroenterology 2006; 131(5) :1561-1572. (Pubitemid 44708943)
39. Colnot S, Decaens T, Niwa Kawakita M et al. Liver-targeted disruption of apc in mice activates beta-catenin signaling and leads to hepatocellular carcinomas. Proc Natl Acad Sci USA 2004; 101(49):17216-17221. (Pubitemid 39627800)
40. Harada N, Miyoshi H, Mural N et al. Lack of tumorigenesis in the mouse liver mer adenovirus-mediated expression of a dominant stable mutant of beta-catenin. Cancer Res 2002; 62(7):1971-1977. (Pubitemid 34408440)
41. Harada N, Oshima H, Katoh M et al. Heparocarcinogenesis in mice with beta-catcnin and ha-ras gene mutations. Cancer Res 2004; 64(1) :48-54. (Pubitemid 38114081)
42. Li F, Xiang Y, Porter J et al. Conditional deletion of c-myc does not impalr liver regeneration. Cancer Res 2006; 66(11) :5608-5612. (Pubitemid 43927111)
43. Pecina Siaus N, PavelicK, PavelicJ. Loss of heterozygosity and protein expression of APC gene in renal cell carcinomas. J Mol Med 1999; 77(5) :446-453. (Pubitemid 29302709)
44. Kim YS, Kang YK, Kim JB et al. beta-catenin expression and mutational analysisin renal cell carcinomas. Pathol Int 2000; 50(9):725-730.
45. Qian CN, Knol J, Igarashi P et al. Cystic renal neoplasia following conditional inactivation of apc in mouse renal tubular epithelium. J Biol Chem 2005; 280(5) :3938-3945. (Pubitemid 40223863)
46. Sansom OJ, Griffiths DF, Reed KR et al. Apc deficiency predisposes to renal carcinoma in the mouse. Oncogene 2005; 24(55):8205-8210. (Pubitemid 41759819)
47. Sansom OJ, Mcniel V, Wilkins JA et al. Loss of apc allows phenotypic manifestation of the transforming properties of an endogenous K-ras oncogene in vivo. Proc Natl Acad Sci USA 2006; 103(38) :14122-14127. (Pubitemid 44452990)
48. Jin Z, Tamura G, Tsuchiya T et al. Adenomatous polyposis coli (APC) gene promoter hypermerhylation in primary breast cancers. Br J Cancer 2001; 85(1) :69-73. (Pubitemid 32695718)
49. Virrnani AK, Rathi A, Sathyanarayana UG et al. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter lA in breast and lung carcinomas. Clin Cancer Res 2001; 7(7):1998-2004. (Pubitemid 32994838)
50. Selbert S, Bentley DJ, Melton OW et al. Efficient BLG-cre mediated gene deletion in the mammary gland. Transgenic Res 1998; 7(5) :387-396. (Pubitemid 28542069)
51. Gallagher RC, Hay T, Mcniel V et al. Inactivation of apc perturbs mammary development, but only directly results in acanthoma in the context of TCF-1 deficiency. Oncogene 2002; 21(42):6446-6457. (Pubitemid 35155449)
52. Mcniel V, Hay T, Douglas Jones A et al. Mutations in apc and p53 synergize to promote mammary neoplasia. Cancer Res 2005; 65(2) :410-416.
53. Sansom OJ, Stark LA, Dunlop MG et al. Suppression of intestinal and mammary neoplasia by lifetime administration of aspirin in apc(Min/+) and apc(Min/+), Msh2(-/-) mice. Cancer Res 2001; 61(19) :7060-7064. (Pubitemid 32946497)
54. Mahmoud NN, Boolbol SK, Dannenberg AJ et al. 'The sulfide metabolite of sulindac prevents tumors and restores enterocyte apoptosis in a murine model of familial adenomatous polyposis. Carcinogenesis 1998; 19(1) :87-91. (Pubitemid 28378517)
55. Mahmoud NN, Dannenberg AJ, Mestre J et al. Aspirin prevents tumors in a murine model of familial adenomatous polyposis. Surgery 1998; 124(2):225-231. (Pubitemid 28372920)